What Was the Starting Date of the COVID-19 Epidemic in Iran? Rumors against Management of Public Health Emergencies

Vardanjani, Hossein Molavi; Lankarani, Kamran Bagheri; Hassani, Amir Hossein

doi:10.18502/ijph.v49i12.4836

Cited by 3 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Iran has not been an exemption in the conflict against COVID-19 and various vaccine preparations are being used in Iran such as Sinopharm for this issue [5]. This vaccine has been proved effective against COVID-19 [6], and fewer side effects are reported for this agent compared to AstraZeneca and Pfizer preparations [7].…”

Section: Introductionmentioning

confidence: 99%

A case report of pericardial effusion as a complication of vaccination against COVID-19 with Sinopharm vaccine

Zibaeenezhad¹,

Hosseini²,

Mohammadi³

et al. 2022

J Clin Images Med Case Rep

View full text Add to dashboard Cite

Background: Sinopharm vaccine is in fact an inactivated form of SARS-CoV-2. This vaccine is one of the agents that are frequently utilized worldwide. The most frequent adverse effects of this vaccine have been local irritation, fever, and fatigue. Case presentation: The case is a 34-year-old male without any previous medical conditions who presented with pleuritic chest pain 48 hours after the inoculation of Sinopharm vaccine. In his transthoracic echocardiography, mild anterior pericardial effusion and moderate posterior pericardial effusion was noted. The patient underwent pericardial window insertion and the bloody pericardial effusion fluid was drained which was lymphocyte rich without any signs of malignancy and the pericardial biopsy showed chronic inflammation and foreign body giant cell. The patient’s PCR for COVID-19 came back negative. The serology tests for COVID-19 were negative as well. Conclusion: Pericardial effusion can be seen rarely as a complication of vaccination with Sinopharm vaccine. This complication might have happened due to improper handling of the vaccine. This complication was resolved without any consequence in our patient; therefore, this vaccine is still counted as safe and effective in preventing COVID-19

show abstract

Section: Introductionmentioning

confidence: 99%

A case report of pericardial effusion as a complication of vaccination against COVID-19 with Sinopharm vaccine

Zibaeenezhad¹,

Hosseini²,

Mohammadi³

et al. 2022

J Clin Images Med Case Rep

View full text Add to dashboard Cite

show abstract

“…Some of these challenges include a high and ever-increasing number of medical scandals propagated in the media alongside a shortage of medicines due to the economic conditions caused by sanctions posed by the United States in recent years. 16 Moreover, lots of rumors have been propagated through social networks and other sources since the moment public announcements were issued regarding the start of the COVID-19 epidemic in Iran. 17 These conditions can severely damage the public trust in healthcare system of the country.…”

Section: Introductionmentioning

confidence: 99%

Public Trust in Healthcare System in Iran: A Rapid Assessment During the COVID-19 Epidemic in Iran

Lankarani

Imanieh

Hassani

et al. 2021

Int J Epidemiol Res

View full text Add to dashboard Cite

Background and aims: Public health policies and programs should be adapted to the level of public trust in the healthcare system, as an indicator of the public support level. Accordingly, the data about public trust level in the healthcare system is considered as a critical requirement for managing public health crises. This study aimed to rapidly assess the public trust in the healthcare system during the COVID-19 epidemic in Iran, as well as to evaluate the effect of socioeconomic status (SES) on this trust. Methods: This cross-sectional and web-based study which was conducted in Iran during the COVID-19 epidemic included adults aged 18-60 years. A probability proportional to size multistage random sampling was applied and performed in 15 provinces of the country. Data on the main sources of information about COVID-19, trust in healthcare system, fear level of COVID-19, and demographics were collected via an electronic questionnaire. Multiple linear regression was applied, and adjusted regression coefficients and 95% confidence intervals (CIs) were estimated. Results: A total of 5250 adults (response rate: 76%) were included in the study. The mean of reported trust scores was 50.3±22.8, and that of fear scores was 72.0±17.8. The highest (65%) and lowest (28%) levels of trust were observed among participants from the lowest and highest SES, respectively. Gender (male) (P=0.006), higher levels of education (P<0.001), higher socio-economic status (P<0.001), and higher fear scores (P<0.001) were independently correlated with the lower level of ⦰ trust in healthcare system. Conclusion: It was found that the public trust in Iran’s healthcare system was not high enough at the time of the COVID-19 epidemic in the country, especially among higher social class population.

show abstract

“… 5 To assess the impact of the COVID‐19 pandemic on routine care (visits and chemotherapy) for patients with solid tumors, we used multivariable Poisson regression, which allowed us to estimate the incidence rate ratio (IRR) in a daily clinic affiliated with the Shiraz University of Medical Sciences. We evaluated a total of 23,256 inpatient visits and 5428 chemotherapy sessions from February 19, 2019 (1 year before the public announcement of the COVID‐19 pandemic in Iran), 6 to November 31, 2021. The results showed annual declines in chemotherapy and in‐person visits of 11% (IRR, 0.89; 95% confidence interval, 0.87‐0.91) and 2% (IRR, 0.98; 95% confidence interval, 0.97‐0.99), respectively.…”

mentioning

confidence: 99%

Cancer treatment in the time of COVID‐19 pandemics: A new concern

Nasrollahi

Vardanjani

2022

Cancer

Self Cite

View full text Add to dashboard Cite

What Was the Starting Date of the COVID-19 Epidemic in Iran? Rumors against Management of Public Health Emergencies

Abstract: The article's abstract is not available.

Cited by 3 publications

References 1 publication

A case report of pericardial effusion as a complication of vaccination against COVID-19 with Sinopharm vaccine

A case report of pericardial effusion as a complication of vaccination against COVID-19 with Sinopharm vaccine

Public Trust in Healthcare System in Iran: A Rapid Assessment During the COVID-19 Epidemic in Iran

Cancer treatment in the time of COVID‐19 pandemics: A new concern

Contact Info

Product

Resources

About